Skip to main content
Rapid Diagnostics Market Analysis, Size, and Forecast 2026-2030: North America (US, Canada, and Mexico), Europe (Germany, UK, and France), Asia (China, India, and Japan), South America (Brazil, Argentina, and Colombia), Middle East and Africa (Saudi Arabia, UAE, and South Africa), Rest of World (ROW)

Rapid Diagnostics Market Analysis, Size, and Forecast 2026-2030:
North America (US, Canada, and Mexico), Europe (Germany, UK, and France), Asia (China, India, and Japan), South America (Brazil, Argentina, and Colombia), Middle East and Africa (Saudi Arabia, UAE, and South Africa), Rest of World (ROW)

Published: Oct 2026 302 Pages SKU: IRTNTR73064

Market Overview at a Glance

$14.31 B
Market Opportunity
7.5%
CAGR 2025 - 2030
44.9%
North America Growth
$17.71 B
Blood glucose segment 2024

Rapid Diagnostics Market Size 2026-2030

The rapid diagnostics market size is valued to increase by USD 14.31 billion, at a CAGR of 7.5% from 2025 to 2030. Escalating global burden of infectious diseases will drive the rapid diagnostics market.

Major Market Trends & Insights

  • North America dominated the market and accounted for a 44.9% growth during the forecast period.
  • By Application - Blood glucose segment was valued at USD 17.71 billion in 2024
  • By Product - Reagents and kits segment accounted for the largest market revenue share in 2024

Market Size & Forecast

  • Market Opportunities: USD 22.88 billion
  • Market Future Opportunities: USD 14.31 billion
  • CAGR from 2025 to 2030 : 7.5%

Market Summary

  • The Rapid Diagnostics Market is undergoing a structural transformation as healthcare systems prioritize decentralized clinical decision-making over traditional laboratory processing. Hospital networks optimizing their emergency triage workflows frequently deploy point-of-care testing platforms to instantly differentiate between viral and bacterial infections. This operational shift has resulted in a 40% reduction in patient wait times, directly lowering emergency department congestion.
  • The escalating burden of infectious diseases acts as a major catalyst, driving urgent demand for portable diagnostic tools capable of containing seasonal outbreaks. Consequently, healthcare providers are heavily investing in rapid testing infrastructure to expedite targeted treatments. However, stringent regulatory scrutiny regarding test accuracy poses a significant barrier to immediate market entry.
  • Developers face prolonged validation cycles to prove clinical sensitivity, which inadvertently slows down the introduction of innovative assays. Ultimately, the successful integration of these advanced diagnostic technologies into existing electronic health record systems continues to streamline patient management, ensuring that actionable clinical insights are delivered efficiently across diverse medical environments.

What will be the Size of the Rapid Diagnostics Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Get Free Sample

How is the Rapid Diagnostics Market Segmented?

The rapid diagnostics industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2026-2030, as well as historical data from 2020-2024 for the following segments.

  • Application
    • Blood glucose
    • Infectious disease
    • Cardiometabolic
    • Pregnancy and fertility
    • Others
  • Product
    • Reagents and kits
    • Instruments
  • Type
    • Over-the-counter (OTC)
    • Prescription
  • Geography
    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • Germany
      • UK
      • France
      • Italy
      • Spain
      • The Netherlands
    • Asia
      • China
      • India
      • Japan
      • South Korea
      • Indonesia
      • Thailand
    • Rest of World (ROW)

By Application Insights

The blood glucose segment is estimated to witness significant growth during the forecast period.

The blood glucose segment fundamentally anchors the Rapid Diagnostics Market by addressing the escalating necessity for real-time metabolic tracking. Traditional capillary blood sampling methodologies utilizing electrochemical test strips are rapidly evolving toward more sophisticated diagnostic solutions.

Modern biological specimen extraction techniques now allow for seamless integration with home-based health monitoring systems, significantly elevating patient compliance. These advancements have catalyzed a 15% improvement in immediate error detection during continuous glucose monitoring protocols compared to legacy systems.

Furthermore, decentralized diagnostic settings report a 25% faster clinical response rate when utilizing advanced lateral flow assays and rapid antigen detection platforms.

By shifting routine metabolic surveillance out of centralized laboratories, healthcare providers effectively reduce institutional bottlenecks and rapidly identify diagnostic biomarker targets.

This continuous operational transition ensures that high-risk patient populations receive vital data instantly, optimizing point-of-care consumable cartridges usage and improving overall clinical decision-making loops across decentralized networks.

Get Free Sample

The Blood glucose segment was valued at USD 17.71 billion in 2024 and showed a gradual increase during the forecast period.

Get Free Sample

Regional Analysis

North America is estimated to contribute 44.9% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

See How Rapid Diagnostics Market Demand is Rising in North America Get Free Sample

The Rapid Diagnostics Market demonstrates distinct operational variances between North America and the APAC region. North America maintains a highly integrated diagnostic infrastructure, utilizing quantitative polymerase chain reaction tools to achieve a 45% faster integration rate into existing clinical workflows.

This rapid adoption is heavily supported by established reimbursement frameworks that prioritize decentralized primary care and portable testing capabilities. Conversely, the APAC region experiences a 30% higher demand growth for cost-effective screening solutions, driven by expanding rural healthcare access.

Facilities in North America report a 25% improvement in hospital readmission reduction through the deployment of high-sensitivity cardiac troponin panels at the point of care.

Meanwhile, APAC supply chains are optimizing distribution channels for lab-on-a-chip cartridges designed for ambulatory surgical centers, reducing delivery bottlenecks by 18%.

Furthermore, the regional implementation of robust antimicrobial stewardship platforms highlights how differing healthcare policies directly influence the deployment scale and operational efficiency globally.

Market Dynamics

Our researchers analyzed the data with 2025 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

  • The operational landscape of the Rapid Diagnostics Market is increasingly defined by the aggressive integration of high-performance analytical tools designed to expedite clinical workflows. Healthcare administrators are shifting their procurement strategies toward rapid point-of-care molecular diagnostics, effectively bypassing the logistical delays inherent in traditional centralized laboratory environments.
  • This transition is further accelerated by the deployment of microfluidic lab-on-a-chip testing platforms, which allow for the precise processing of minute biological samples while reducing chemical reagent consumption by nearly 40% compared to legacy benchtop equipment. This substantial reduction directly impacts supply chain planning, lowering inventory storage requirements for consumable materials.
  • Furthermore, the escalating consumer preference for autonomous health management has catalyzed the widespread distribution of over-the-counter self-administered diagnostic kits. Retail pharmacies and community clinics are expanding their product offerings to include these accessible solutions, enhancing preventative care strategies.
  • In tandem, the management of metabolic disorders is being revolutionized by decentralized continuous glucose monitoring devices, which provide uninterrupted physiological data streams that optimize long-term treatment adherence. During peak seasonal illness cycles, the utilization of rapid multiplex respiratory pathogen panels allows physicians to distinguish overlapping viral symptoms instantly, thereby improving targeted antimicrobial stewardship.
  • By prioritizing these sophisticated, decentralized technologies, medical networks significantly enhance their operational throughput, reduce unnecessary clinical admissions, and ensure that critical patient data is captured and acted upon with unprecedented efficiency.

What are the key market drivers leading to the rise in the adoption of Rapid Diagnostics Industry?

  • The escalating global burden of infectious diseases serves as a primary market driver, compelling healthcare systems to rapidly adopt decentralized testing platforms for immediate pathogen identification and outbreak containment.

  • The imperative to expedite emergency triage procedures is acting as a massive operational driver within the Rapid Diagnostics Market. Hospitals face immense pressure to mitigate patient bottlenecks, prompting a decisive shift toward decentralized medical diagnostics.
  • By deploying advanced point-of-care testing systems and automated benchtop analyzers, clinical networks generate actionable clinical insights instantly, resulting in a 40% reduction in patient wait times.
  • This behavioral change toward patient-centric diagnostic models is highly evident in the widespread adoption of rapid immunoassay screening and qualitative biomarker quantification techniques.
  • Consequently, healthcare facilities utilizing these tools for infectious disease screening observe a 25% improvement in resource allocation efficiency. Ultimately, shortening the diagnostic turnaround time significantly optimizes long-term clinical workflows and enhances overall institutional throughput, proving critical for immediate therapeutic administration.

What are the market trends shaping the Rapid Diagnostics Industry?

  • The transition toward multiplex testing in modern diagnostics represents a pivotal market trend, enabling the simultaneous detection of multiple pathogens from a single clinical specimen.

  • The widespread adoption of multiplex diagnostic panels is fundamentally transforming the Rapid Diagnostics Market by enabling comprehensive pathogen detection from a single patient sample. This technological shift is driven by the urgent clinical need to eliminate sequential testing protocols during overlapping seasonal outbreaks. Consequently, facilities utilizing syndromic respiratory panels alongside hand-held diagnostic readers experience a 30% decrease in processing times.
  • This rapid clinical intervention significantly improves targeted therapeutic strategies. Furthermore, the seamless integration of digital health connectivity frameworks ensures that test results derived from optical fluorescence detection and surface plasmon resonance sensors are transmitted instantaneously, enhancing electronic health record interoperability by 25% over previous manual entry systems.
  • By streamlining these analytical workflows through predictive clinical analytics, healthcare providers not only optimize their diagnostic workflow integration but also reduce administrative burdens by 18%, proving digitized testing platforms are essential.

What challenges does the Rapid Diagnostics Industry face during its growth?

  • Heightened regulatory scrutiny and accuracy concerns present a formidable market challenge, demanding extensive clinical validation and increasing the commercialization timeline for novel diagnostic assays.

  • Stringent regulatory validation frameworks continue to present substantial structural limitations within the Rapid Diagnostics Market. As developers engineer highly complex microfluidic biosensors and isothermal nucleic acid amplification systems, they must navigate rigorous compliance mandates. This intense scrutiny inevitably extends product lifecycles, causing a 25% increase in pre-market approval delays for decentralized molecular testing devices.
  • Furthermore, maintaining diagnostic reagent stability across variable environmental conditions poses severe logistical hurdles, especially for over-the-counter testing kits and immunochromatographic strips distributed outside traditional clinical settings. Consequently, diagnostic manufacturers face a 15% rise in operational quality control costs during infectious pathogen surveillance initiatives.
  • The volatility in procuring highly specialized supply chain raw materials further complicates high-throughput assay execution, leading to a 20% variance in production timelines, requiring robust resilience strategies to maintain market viability.

Exclusive Technavio Analysis on Customer Landscape

The rapid diagnostics market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the rapid diagnostics market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Customer Landscape of Rapid Diagnostics Industry

Competitive Landscape

Companies are implementing various strategies, such as strategic alliances, rapid diagnostics market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

A. Menarini Diagnostics S.r.l. - The organization delivers advanced point-of-care testing solutions, including multiplex respiratory panels and microfluidic diagnostic devices, designed to accelerate clinical decision-making and optimize decentralized healthcare workflows effectively.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

  • A. Menarini Diagnostics S.r.l.
  • Abbott Laboratories
  • Access Bio Inc.
  • ACON Laboratories Inc.
  • Becton Dickinson and Co.
  • BioMerieux SA
  • BIOSYNEX SA
  • Cardinal Health Inc.
  • Cepheid Inc.
  • DAAN Gene Co. Ltd.
  • DiaSorin SpA
  • F. Hoffmann La Roche Ltd.
  • Guangzhou Wondfo Biotech Co. Ltd.
  • Hologic Inc.
  • Jiangsu Orient Gene Biotech
  • Meridian Bioscience Inc.
  • Nova Biomedical Corp.
  • QuidelOrtho Corp.
  • Revvity Inc.
  • Sekisui Diagnostics LLC
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Werfenlife SA

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Development and News in Rapid diagnostics market

  • In the Life Sciences Tools and Services industry, the broad integration of advanced microfluidic manufacturing techniques has reduced consumable production costs by 18%, directly impacting the Rapid Diagnostics market by making high-throughput assay execution more affordable for decentralized clinics.
  • The implementation of stringent data privacy regulations under GDPR for patient-linked diagnostic hardware has forced a 25% increase in cybersecurity compliance spending, reshaping how electronic health record interoperability is engineered within new point-of-care consumable cartridges.
  • Supply chain shifts toward regionalized raw material sourcing for specialized biological reagents have decreased logistics-related delays by 30%, subsequently accelerating the availability of rapid antigen detection platforms during infectious pathogen surveillance initiatives.
  • The transition toward value-based care reimbursement models has driven a 40% rise in the adoption of predictive clinical analytics, directly pulling demand for advanced diagnostic workflow integration tools that ensure accurate rapid clinical intervention.

Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Rapid Diagnostics Market insights. See full methodology.

Market Scope
Page number 302
Base year 2025
Historic period 2020-2024
Forecast period 2026-2030
Growth momentum & CAGR Accelerate at a CAGR of 7.5%
Market growth 2026-2030 USD 14306.1 million
Market structure Fragmented
YoY growth 2025-2026(%) 7.0%
Key countries US, Canada, Mexico, Germany, UK, France, Italy, Spain, The Netherlands, China, India, Japan, South Korea, Indonesia, Thailand, Brazil, Argentina, Saudi Arabia, Colombia, UAE, South Africa, Israel and Turkey
Competitive landscape Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Request Free Sample

Research Analyst Overview

  • The Rapid Diagnostics Market is experiencing a profound technological evolution characterized by the rapid transition from centralized laboratory testing to decentralized point-of-care testing. Medical networks are strategically integrating isothermal nucleic acid amplification platforms to accelerate clinical decision-making during acute patient consultations.
  • This shift directly influences operational budgeting, as hospitals deploying these advanced systems observe a 35% reduction in patient processing time compared to traditional analytical methods. Manufacturers are prioritizing the development of microfluidic biosensors and immunochromatographic strips to deliver precise, qualitative biomarker quantification in resource-limited settings.
  • By embedding these sophisticated technologies into compact lab-on-a-chip cartridges, developers significantly reduce sample volume requirements while maintaining high diagnostic accuracy. Furthermore, the implementation of automated optical fluorescence detection mechanisms within portable readers minimizes human interpretation errors, ensuring robust compliance with rigorous clinical standards.
  • These continuous advancements in diagnostic reagent stability and hardware engineering empower healthcare providers to optimize triage protocols, strictly align with antimicrobial stewardship mandates, and ultimately enhance the operational efficiency of global medical infrastructures.

What are the Key Data Covered in this Rapid Diagnostics Market Research and Growth Report?

  • What is the expected growth of the Rapid Diagnostics Market between 2026 and 2030?

    • USD 14.31 billion, at a CAGR of 7.5%

  • What segmentation does the market report cover?

    • The report is segmented by Application (Blood glucose, Infectious disease, Cardiometabolic, Pregnancy and fertility, and Others), Product (Reagents and kits, and Instruments), Type (Over-the-counter (OTC), and Prescription) and Geography (North America, Europe, Asia, Rest of World (ROW))

  • Which regions are analyzed in the report?

    • North America, Europe, Asia and Rest of World (ROW)

  • What are the key growth drivers and market challenges?

    • Escalating global burden of infectious diseases, Regulatory scrutiny and accuracy concerns

  • Who are the major players in the Rapid Diagnostics Market?

    • A. Menarini Diagnostics S.r.l., Abbott Laboratories, Access Bio Inc., ACON Laboratories Inc., Becton Dickinson and Co., BioMerieux SA, BIOSYNEX SA, Cardinal Health Inc., Cepheid Inc., DAAN Gene Co. Ltd., DiaSorin SpA, F. Hoffmann La Roche Ltd., Guangzhou Wondfo Biotech Co. Ltd., Hologic Inc., Jiangsu Orient Gene Biotech, Meridian Bioscience Inc., Nova Biomedical Corp., QuidelOrtho Corp., Revvity Inc., Sekisui Diagnostics LLC, Siemens Healthineers AG, Thermo Fisher Scientific Inc. and Werfenlife SA

Market Research Insights

  • The Rapid Diagnostics Market is rapidly shifting toward patient-centric diagnostic models to enhance overall healthcare delivery. By leveraging decentralized medical diagnostics, facilities achieve a 35% reduction in diagnostic turnaround time, substantially improving emergency triage procedures. Implementing these advanced systems yields a 20% improvement in clinical decision-making loops, allowing physicians to initiate targeted therapies with unprecedented speed.
  • Furthermore, the integration of digital health connectivity tools has optimized data transmission, leading to a 15% decrease in operational reporting errors. As hospitals focus on hospital readmission reduction, the seamless deployment of portable testing solutions ensures that critical biological data is captured instantly, maximizing procedural efficiency and aligning strictly with stringent quality compliance mandates across modern medical networks.

We can help! Our analysts can customize this rapid diagnostics market research report to meet your requirements.

Get in touch

1. Executive Summary

1.1 Market overview

Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2. Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

2.2 Criticality of inputs and Factors of differentiation

Chart on Overview on criticality of inputs and factors of differentiation

2.3 Factors of disruption

Chart on Overview on factors of disruption

2.4 Impact of drivers and challenges

Chart on Impact of drivers and challenges in 2025 and 2030

3. Market Landscape

3.1 Market ecosystem

Chart on Parent Market
Data Table on - Parent Market

3.2 Market characteristics

Chart on Market characteristics analysis

3.3 Value chain analysis

Chart on Value chain analysis

4. Market Sizing

4.1 Market definition

Data Table on Offerings of companies included in the market definition

4.2 Market segment analysis

Market segments

4.3 Market size 2025

4.4 Market outlook: Forecast for 2025-2030

Chart on Global - Market size and forecast 2025-2030 ($ million)
Data Table on Global - Market size and forecast 2025-2030 ($ million)
Chart on Global Market: Year-over-year growth 2025-2030 (%)
Data Table on Global Market: Year-over-year growth 2025-2030 (%)

5. Historic Market Size

5.1 Global Rapid Diagnostics Market 2020 - 2024

Historic Market Size - Data Table on Global Rapid Diagnostics Market 2020 - 2024 ($ million)

5.2 Application segment analysis 2020 - 2024

Historic Market Size - Application Segment 2020 - 2024 ($ million)

5.3 Product segment analysis 2020 - 2024

Historic Market Size - Product Segment 2020 - 2024 ($ million)

5.4 Type segment analysis 2020 - 2024

Historic Market Size - Type Segment 2020 - 2024 ($ million)

5.5 Geography segment analysis 2020 - 2024

Historic Market Size - Geography Segment 2020 - 2024 ($ million)

5.6 Country segment analysis 2020 - 2024

Historic Market Size - Country Segment 2020 - 2024 ($ million)

6. Qualitative Analysis

6.1 Impact of AI on Global Rapid Diagnostics Market

6.2 Impact of geopolitical conflicts on Global Rapid Diagnostics Market

7. Five Forces Analysis

7.1 Five forces summary

Five forces analysis - Comparison between 2025 and 2030

7.2 Bargaining power of buyers

Bargaining power of buyers - Impact of key factors 2025 and 2030

7.3 Bargaining power of suppliers

Bargaining power of suppliers - Impact of key factors in 2025 and 2030

7.4 Threat of new entrants

Threat of new entrants - Impact of key factors in 2025 and 2030

7.5 Threat of substitutes

Threat of substitutes - Impact of key factors in 2025 and 2030

7.6 Threat of rivalry

Threat of rivalry - Impact of key factors in 2025 and 2030

7.7 Market condition

Chart on Market condition - Five forces 2025 and 2030

8. Market Segmentation by Application

8.1 Market segments

Chart on Application - Market share 2025-2030 (%)
Data Table on Application - Market share 2025-2030 (%)

8.2 Comparison by Application

Chart on Comparison by Application
Data Table on Comparison by Application

8.3 Blood glucose - Market size and forecast 2025-2030

Chart on Blood glucose - Market size and forecast 2025-2030 ($ million)
Data Table on Blood glucose - Market size and forecast 2025-2030 ($ million)
Chart on Blood glucose - Year-over-year growth 2025-2030 (%)
Data Table on Blood glucose - Year-over-year growth 2025-2030 (%)

8.4 Infectious disease - Market size and forecast 2025-2030

Chart on Infectious disease - Market size and forecast 2025-2030 ($ million)
Data Table on Infectious disease - Market size and forecast 2025-2030 ($ million)
Chart on Infectious disease - Year-over-year growth 2025-2030 (%)
Data Table on Infectious disease - Year-over-year growth 2025-2030 (%)

8.5 Cardiometabolic - Market size and forecast 2025-2030

Chart on Cardiometabolic - Market size and forecast 2025-2030 ($ million)
Data Table on Cardiometabolic - Market size and forecast 2025-2030 ($ million)
Chart on Cardiometabolic - Year-over-year growth 2025-2030 (%)
Data Table on Cardiometabolic - Year-over-year growth 2025-2030 (%)

8.6 Pregnancy and fertility - Market size and forecast 2025-2030

Chart on Pregnancy and fertility - Market size and forecast 2025-2030 ($ million)
Data Table on Pregnancy and fertility - Market size and forecast 2025-2030 ($ million)
Chart on Pregnancy and fertility - Year-over-year growth 2025-2030 (%)
Data Table on Pregnancy and fertility - Year-over-year growth 2025-2030 (%)

8.7 Others - Market size and forecast 2025-2030

Chart on Others - Market size and forecast 2025-2030 ($ million)
Data Table on Others - Market size and forecast 2025-2030 ($ million)
Chart on Others - Year-over-year growth 2025-2030 (%)
Data Table on Others - Year-over-year growth 2025-2030 (%)

8.8 Market opportunity by Application

Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)

9. Market Segmentation by Product

9.1 Market segments

Chart on Product - Market share 2025-2030 (%)
Data Table on Product - Market share 2025-2030 (%)

9.2 Comparison by Product

Chart on Comparison by Product
Data Table on Comparison by Product

9.3 Reagents and kits - Market size and forecast 2025-2030

Chart on Reagents and kits - Market size and forecast 2025-2030 ($ million)
Data Table on Reagents and kits - Market size and forecast 2025-2030 ($ million)
Chart on Reagents and kits - Year-over-year growth 2025-2030 (%)
Data Table on Reagents and kits - Year-over-year growth 2025-2030 (%)

9.4 Instruments - Market size and forecast 2025-2030

Chart on Instruments - Market size and forecast 2025-2030 ($ million)
Data Table on Instruments - Market size and forecast 2025-2030 ($ million)
Chart on Instruments - Year-over-year growth 2025-2030 (%)
Data Table on Instruments - Year-over-year growth 2025-2030 (%)

9.5 Market opportunity by Product

Market opportunity by Product ($ million)
Data Table on Market opportunity by Product ($ million)

10. Market Segmentation by Type

10.1 Market segments

Chart on Type - Market share 2025-2030 (%)
Data Table on Type - Market share 2025-2030 (%)

10.2 Comparison by Type

Chart on Comparison by Type
Data Table on Comparison by Type

10.3 Over-the-counter (OTC) - Market size and forecast 2025-2030

Chart on Over-the-counter (OTC) - Market size and forecast 2025-2030 ($ million)
Data Table on Over-the-counter (OTC) - Market size and forecast 2025-2030 ($ million)
Chart on Over-the-counter (OTC) - Year-over-year growth 2025-2030 (%)
Data Table on Over-the-counter (OTC) - Year-over-year growth 2025-2030 (%)

10.4 Prescription - Market size and forecast 2025-2030

Chart on Prescription - Market size and forecast 2025-2030 ($ million)
Data Table on Prescription - Market size and forecast 2025-2030 ($ million)
Chart on Prescription - Year-over-year growth 2025-2030 (%)
Data Table on Prescription - Year-over-year growth 2025-2030 (%)

10.5 Market opportunity by Type

Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)

11. Customer Landscape

11.1 Customer landscape overview

Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12. Geographic Landscape

12.1 Geographic segmentation

Chart on Market share by geography 2025-2030 (%)
Data Table on Market share by geography 2025-2030 (%)

12.2 Geographic comparison

Chart on Geographic comparison
Data Table on Geographic comparison

12.3 North America - Market size and forecast 2025-2030

Chart on North America - Market size and forecast 2025-2030 ($ million)
Data Table on North America - Market size and forecast 2025-2030 ($ million)
Chart on North America - Year-over-year growth 2025-2030 (%)
Data Table on North America - Year-over-year growth 2025-2030 (%)
Chart on Regional Comparison - North America
Data Table on Regional Comparison - North America

12.3.1 US - Market size and forecast 2025-2030

Chart on US - Market size and forecast 2025-2030 ($ million)
Data Table on US - Market size and forecast 2025-2030 ($ million)
Chart on US - Year-over-year growth 2025-2030 (%)
Data Table on US - Year-over-year growth 2025-2030 (%)

12.3.2 Canada - Market size and forecast 2025-2030

Chart on Canada - Market size and forecast 2025-2030 ($ million)
Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Chart on Canada - Year-over-year growth 2025-2030 (%)
Data Table on Canada - Year-over-year growth 2025-2030 (%)

12.3.3 Mexico - Market size and forecast 2025-2030

Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Chart on Mexico - Year-over-year growth 2025-2030 (%)
Data Table on Mexico - Year-over-year growth 2025-2030 (%)

12.4 Europe - Market size and forecast 2025-2030

Chart on Europe - Market size and forecast 2025-2030 ($ million)
Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Chart on Europe - Year-over-year growth 2025-2030 (%)
Data Table on Europe - Year-over-year growth 2025-2030 (%)
Chart on Regional Comparison - Europe
Data Table on Regional Comparison - Europe

12.4.1 Germany - Market size and forecast 2025-2030

Chart on Germany - Market size and forecast 2025-2030 ($ million)
Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Chart on Germany - Year-over-year growth 2025-2030 (%)
Data Table on Germany - Year-over-year growth 2025-2030 (%)

12.4.2 UK - Market size and forecast 2025-2030

Chart on UK - Market size and forecast 2025-2030 ($ million)
Data Table on UK - Market size and forecast 2025-2030 ($ million)
Chart on UK - Year-over-year growth 2025-2030 (%)
Data Table on UK - Year-over-year growth 2025-2030 (%)

12.4.3 France - Market size and forecast 2025-2030

Chart on France - Market size and forecast 2025-2030 ($ million)
Data Table on France - Market size and forecast 2025-2030 ($ million)
Chart on France - Year-over-year growth 2025-2030 (%)
Data Table on France - Year-over-year growth 2025-2030 (%)

12.4.4 Italy - Market size and forecast 2025-2030

Chart on Italy - Market size and forecast 2025-2030 ($ million)
Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Chart on Italy - Year-over-year growth 2025-2030 (%)
Data Table on Italy - Year-over-year growth 2025-2030 (%)

12.4.5 Spain - Market size and forecast 2025-2030

Chart on Spain - Market size and forecast 2025-2030 ($ million)
Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Chart on Spain - Year-over-year growth 2025-2030 (%)
Data Table on Spain - Year-over-year growth 2025-2030 (%)

12.4.6 The Netherlands - Market size and forecast 2025-2030

Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)

12.5 Asia - Market size and forecast 2025-2030

Chart on Asia - Market size and forecast 2025-2030 ($ million)
Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Chart on Asia - Year-over-year growth 2025-2030 (%)
Data Table on Asia - Year-over-year growth 2025-2030 (%)
Chart on Regional Comparison - Asia
Data Table on Regional Comparison - Asia

12.5.1 China - Market size and forecast 2025-2030

Chart on China - Market size and forecast 2025-2030 ($ million)
Data Table on China - Market size and forecast 2025-2030 ($ million)
Chart on China - Year-over-year growth 2025-2030 (%)
Data Table on China - Year-over-year growth 2025-2030 (%)

12.5.2 India - Market size and forecast 2025-2030

Chart on India - Market size and forecast 2025-2030 ($ million)
Data Table on India - Market size and forecast 2025-2030 ($ million)
Chart on India - Year-over-year growth 2025-2030 (%)
Data Table on India - Year-over-year growth 2025-2030 (%)

12.5.3 Japan - Market size and forecast 2025-2030

Chart on Japan - Market size and forecast 2025-2030 ($ million)
Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Chart on Japan - Year-over-year growth 2025-2030 (%)
Data Table on Japan - Year-over-year growth 2025-2030 (%)

12.5.4 South Korea - Market size and forecast 2025-2030

Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Chart on South Korea - Year-over-year growth 2025-2030 (%)
Data Table on South Korea - Year-over-year growth 2025-2030 (%)

12.5.5 Indonesia - Market size and forecast 2025-2030

Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Data Table on Indonesia - Year-over-year growth 2025-2030 (%)

12.5.6 Thailand - Market size and forecast 2025-2030

Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Chart on Thailand - Year-over-year growth 2025-2030 (%)
Data Table on Thailand - Year-over-year growth 2025-2030 (%)

12.6 Rest of World (ROW) - Market size and forecast 2025-2030

Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Chart on Regional Comparison - Rest of World (ROW)
Data Table on Regional Comparison - Rest of World (ROW)

12.6.1 Brazil - Market size and forecast 2025-2030

Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Chart on Brazil - Year-over-year growth 2025-2030 (%)
Data Table on Brazil - Year-over-year growth 2025-2030 (%)

12.6.2 Argentina - Market size and forecast 2025-2030

Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Chart on Argentina - Year-over-year growth 2025-2030 (%)
Data Table on Argentina - Year-over-year growth 2025-2030 (%)

12.6.3 Saudi Arabia - Market size and forecast 2025-2030

Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)

12.6.4 Colombia - Market size and forecast 2025-2030

Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Chart on Colombia - Year-over-year growth 2025-2030 (%)
Data Table on Colombia - Year-over-year growth 2025-2030 (%)

12.6.5 UAE - Market size and forecast 2025-2030

Chart on UAE - Market size and forecast 2025-2030 ($ million)
Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Chart on UAE - Year-over-year growth 2025-2030 (%)
Data Table on UAE - Year-over-year growth 2025-2030 (%)

12.6.6 South Africa - Market size and forecast 2025-2030

Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Chart on South Africa - Year-over-year growth 2025-2030 (%)
Data Table on South Africa - Year-over-year growth 2025-2030 (%)

12.6.7 Israel - Market size and forecast 2025-2030

Chart on Israel - Market size and forecast 2025-2030 ($ million)
Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Chart on Israel - Year-over-year growth 2025-2030 (%)
Data Table on Israel - Year-over-year growth 2025-2030 (%)

12.6.8 Turkey - Market size and forecast 2025-2030

Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Chart on Turkey - Year-over-year growth 2025-2030 (%)
Data Table on Turkey - Year-over-year growth 2025-2030 (%)

12.7 Market opportunity by geography

Market opportunity by geography ($ million)
Data Tables on Market opportunity by geography ($ million)

13. Drivers, Challenges, and Opportunity

13.1 Market drivers

Escalating global burden of infectious diseases
Widespread shift toward decentralized medical diagnostics
Technological progress in biosensors and microfluidics

13.2 Market challenges

Regulatory scrutiny and accuracy concerns
Complex reimbursement and cost pressures
Integration of artificial intelligence tools

13.3 Impact of drivers and challenges

Impact of drivers and challenges in 2025 and 2030

13.4 Market opportunities

Multiplex testing in modern diagnostics
Antimicrobial stewardship in clinical practice
Microfluidic innovations in rapid point care

14. Competitive Landscape

14.1 Overview

14.2

Overview on criticality of inputs and factors of differentiation

14.3 Landscape disruption

Overview on factors of disruption

14.4 Industry risks

Impact of key risks on business

15. Competitive Analysis

15.1 Companies profiled

Companies covered

15.2 Company ranking index

15.3 Market positioning of companies

Matrix on companies position and classification

15.4 A. Menarini Diagnostics S.r.l.

A. Menarini Diagnostics S.r.l. - Overview
A. Menarini Diagnostics S.r.l. - Product / Service
A. Menarini Diagnostics S.r.l. - Key offerings
SWOT

15.5 Abbott Laboratories

Abbott Laboratories - Overview
Abbott Laboratories - Business segments
Abbott Laboratories - Key news
Abbott Laboratories - Key offerings
Abbott Laboratories - Segment focus
SWOT

15.6 Becton Dickinson and Co.

Becton Dickinson and Co. - Overview
Becton Dickinson and Co. - Business segments
Becton Dickinson and Co. - Key news
Becton Dickinson and Co. - Key offerings
Becton Dickinson and Co. - Segment focus
SWOT

15.7 BioMerieux SA

BioMerieux SA - Overview
BioMerieux SA - Business segments
BioMerieux SA - Key offerings
BioMerieux SA - Segment focus
SWOT

15.8 Cardinal Health Inc.

Cardinal Health Inc. - Overview
Cardinal Health Inc. - Business segments
Cardinal Health Inc. - Key news
Cardinal Health Inc. - Key offerings
Cardinal Health Inc. - Segment focus
SWOT

15.9 DiaSorin SpA

DiaSorin SpA - Overview
DiaSorin SpA - Business segments
DiaSorin SpA - Key news
DiaSorin SpA - Key offerings
DiaSorin SpA - Segment focus
SWOT

15.10 F. Hoffmann La Roche Ltd.

F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
SWOT

15.11 Hologic Inc.

Hologic Inc. - Overview
Hologic Inc. - Product / Service
Hologic Inc. - Key offerings
SWOT

15.12 Meridian Bioscience Inc.

Meridian Bioscience Inc. - Overview
Meridian Bioscience Inc. - Product / Service
Meridian Bioscience Inc. - Key offerings
SWOT

15.13 Nova Biomedical Corp.

Nova Biomedical Corp. - Overview
Nova Biomedical Corp. - Product / Service
Nova Biomedical Corp. - Key offerings
SWOT

15.14 QuidelOrtho Corp.

QuidelOrtho Corp. - Overview
QuidelOrtho Corp. - Business segments
QuidelOrtho Corp. - Key offerings
QuidelOrtho Corp. - Segment focus
SWOT

15.15 Revvity Inc.

Revvity Inc. - Overview
Revvity Inc. - Business segments
Revvity Inc. - Key offerings
Revvity Inc. - Segment focus
SWOT

15.16 Sekisui Diagnostics LLC

Sekisui Diagnostics LLC - Overview
Sekisui Diagnostics LLC - Product / Service
Sekisui Diagnostics LLC - Key offerings
SWOT

15.17 Siemens Healthineers AG

Siemens Healthineers AG - Overview
Siemens Healthineers AG - Business segments
Siemens Healthineers AG - Key offerings
Siemens Healthineers AG - Segment focus
SWOT

15.18 Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. - Overview
Thermo Fisher Scientific Inc. - Business segments
Thermo Fisher Scientific Inc. - Key news
Thermo Fisher Scientific Inc. - Key offerings
Thermo Fisher Scientific Inc. - Segment focus
SWOT

16. Appendix

16.1 Scope of the report

Market definition
Objectives
Notes and caveats

16.2 Inclusions and exclusions checklist

Inclusions checklist
Exclusions checklist

16.3 Currency conversion rates for US$

16.4 Research methodology

16.5 Data procurement

Information sources

16.6 Data validation

16.7 Validation techniques employed for market sizing

16.8 Data synthesis

16.9 360 degree market analysis

16.10 List of abbreviations

Research Methodology

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

Interested in this report?

Get your sample now to see our research methodology and insights!

Download Now

Frequently Asked Questions

Rapid Diagnostics market growth will increase by USD 14306.1 million during 2026-2030.

The Rapid Diagnostics market is expected to grow at a CAGR of 7.5% during 2026-2030.

Rapid Diagnostics market is segmented by Application (Blood glucose, Infectious disease, Cardiometabolic, Pregnancy and fertility, Others) Product (Reagents and kits, Instruments) Type (Over-the-counter (OTC), Prescription)

A. Menarini Diagnostics S.r.l., Abbott Laboratories, Access Bio Inc., ACON Laboratories Inc., Becton Dickinson and Co., BioMerieux SA, BIOSYNEX SA, Cardinal Health Inc., Cepheid Inc., DAAN Gene Co. Ltd., DiaSorin SpA, F. Hoffmann La Roche Ltd., Guangzhou Wondfo Biotech Co. Ltd., Hologic Inc., Jiangsu Orient Gene Biotech, Meridian Bioscience Inc., Nova Biomedical Corp., QuidelOrtho Corp., Revvity Inc., Sekisui Diagnostics LLC, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Werfenlife SA are a few of the key vendors in the Rapid Diagnostics market.

North America will register the highest growth rate of 44.9% among the other regions. Therefore, the Rapid Diagnostics market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

US, Canada, Mexico, Germany, UK, France, Italy, Spain, The Netherlands, China, India, Japan, South Korea, Indonesia, Thailand, Brazil, Argentina, Saudi Arabia, Colombia, UAE, South Africa, Israel, Turkey

  • Escalating global burden of infectious diseases is the driving factor this market.

The Rapid Diagnostics market vendors should focus on grabbing business opportunities from the Application segment as it accounted for the largest market share in the base year.
RIA - Research AI Assistant
Ask RIA